266 related articles for article (PubMed ID: 32171146)
1. UHPLC Q-Exactive MS-based spleen metabolomics and lipidomics to explore the effect mechanisms of Danggui Buxue Decoction in anemia mice.
Liu Y; Li X; Li A; Li K; Qin X
J Pharm Biomed Anal; 2020 Jun; 185():113234. PubMed ID: 32171146
[TBL] [Abstract][Full Text] [Related]
2. Integration of organ metabolomics and proteomics in exploring the blood enriching mechanism of Danggui Buxue Decoction in hemorrhagic anemia rats.
Shi XQ; Zhu ZH; Yue SJ; Tang YP; Chen YY; Pu ZJ; Tao HJ; Zhou GS; Yang Y; Guo MJ; Ting-Xia Dong T; Tsim KW; Duan JA
J Ethnopharmacol; 2020 Oct; 261():113000. PubMed ID: 32663590
[TBL] [Abstract][Full Text] [Related]
3. Studies on the compatibility mechanism and material basis of Danggui Buxue Decoction against anemia mice using metabonomics and network pharmacology.
Liu Y; Ju Y; Qin X
J Pharm Pharmacol; 2021 Apr; 73(6):767-777. PubMed ID: 33769518
[TBL] [Abstract][Full Text] [Related]
4. Urine and plasma metabonomics coupled with UHPLC-QTOF/MS and multivariate data analysis on potential biomarkers in anemia and hematinic effects of herb pair Gui-Hong.
Li S; Lin H; Qu C; Tang Y; Shen J; Li W; Yue S; Kai J; Shang G; Zhu Z; Zhang C; Liu P; Yan H; Zhang L; Qian L; Qian D; Duan JA
J Ethnopharmacol; 2015 Jul; 170():175-83. PubMed ID: 25985767
[TBL] [Abstract][Full Text] [Related]
5. A novel approach based on metabolomics coupled with network pharmacology to explain the effect mechanisms of Danggui Buxue Tang in anaemia.
Hua YL; Ma Q; Yuan ZW; Zhang XS; Yao WL; Ji P; Hu JJ; Wei YM
Chin J Nat Med; 2019 Apr; 17(4):275-290. PubMed ID: 31076131
[TBL] [Abstract][Full Text] [Related]
6. [Metabolomics study of Danggui Buxue Tang on treatment of type 2 diabetes mice using UHPLC-Q-TOF-MS].
Sun LL; Bai HY; Zheng WH; Wang LY; Zhao W; Li JY; Shi YB; Yang ZG
Zhongguo Zhong Yao Za Zhi; 2020 Feb; 45(3):636-644. PubMed ID: 32237524
[TBL] [Abstract][Full Text] [Related]
7. Dynamic urinary metabolomics analysis based on UHPLC-Q-TOF/MS to investigate the potential biomarkers of blood stasis syndrome and the effects of Danggui Sini decoction.
Huang H; Wu J; Lu R; Liu X; Chin B; Zhu H; Yin C; Cheng B; Wu Z; Chen X; Liang Y; Song H; Zheng H; Guo H; Su Z
J Pharm Biomed Anal; 2020 Feb; 179():112986. PubMed ID: 31787459
[TBL] [Abstract][Full Text] [Related]
8. Integrated lipidomics, transcriptomics and network pharmacology analysis to reveal the mechanisms of Danggui Buxue Decoction in the treatment of diabetic nephropathy in type 2 diabetes mellitus.
Sun L; Yang Z; Zhao W; Chen Q; Bai H; Wang S; Yang L; Bi C; Shi Y; Liu Y
J Ethnopharmacol; 2022 Jan; 283():114699. PubMed ID: 34610419
[TBL] [Abstract][Full Text] [Related]
9. An unbiased lipidomics approach identifies key lipid molecules as potential therapeutic targets of Dohongsamul-tang against non-alcoholic fatty liver diseases in a mouse model of obesity.
Park SH; Lee JE; Lee SM; Lee J; Seo CS; Hwang GS; Jung J
J Ethnopharmacol; 2020 Oct; 260():112999. PubMed ID: 32454173
[TBL] [Abstract][Full Text] [Related]
10. A network pharmacology approach to investigate the blood enriching mechanism of Danggui buxue Decoction.
Shi XQ; Yue SJ; Tang YP; Chen YY; Zhou GS; Zhang J; Zhu ZH; Liu P; Duan JA
J Ethnopharmacol; 2019 May; 235():227-242. PubMed ID: 30703496
[TBL] [Abstract][Full Text] [Related]
11. Comparative tissue distribution profiles of five major bio-active components in normal and blood deficiency rats after oral administration of Danggui Buxue Decoction by UPLC-TQ/MS.
Shi X; Tang Y; Zhu H; Li W; Li Z; Li W; Duan JA
J Pharm Biomed Anal; 2014 Jan; 88():207-15. PubMed ID: 24076576
[TBL] [Abstract][Full Text] [Related]
12. Untargeted lipidomics analysis of Mori Fructus polysaccharide on acute alcoholic liver injury in mice using ultra performance liquid chromatography-quadrupole-orbitrap-high resolution mass spectrometry.
Bian L; Chen H; Zhou X
Int Immunopharmacol; 2021 Aug; 97():107521. PubMed ID: 33940322
[TBL] [Abstract][Full Text] [Related]
13. Untargeted metabolomics and lipidomics uncovering the cardioprotective effects of Huanglian Jiedu Decoction on pathological cardiac hypertrophy and remodeling.
Chen QQ; Wang FX; Cai YY; Zhang YK; Fang JK; Qi LW; Zhang L; Huang FQ
J Ethnopharmacol; 2021 Apr; 270():113646. PubMed ID: 33264659
[TBL] [Abstract][Full Text] [Related]
14. Metabolomics analysis of serum reveals the effect of Danggui Buxue Tang on fatigued mice induced by exhausting physical exercise.
Miao X; Xiao B; Shui S; Yang J; Huang R; Dong J
J Pharm Biomed Anal; 2018 Mar; 151():301-309. PubMed ID: 29413978
[TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetic comparison of seven major bio-active components in normal and blood deficiency rats after oral administration of Danggui Buxue decoction by UPLC-TQ/MS.
Shi X; Tang Y; Zhu H; Li W; Li W; Li Z; Luo N; Duan JA
J Ethnopharmacol; 2014 Apr; 153(1):169-77. PubMed ID: 24583239
[TBL] [Abstract][Full Text] [Related]
16. High-throughput lipidomics analysis to discover lipid biomarkers and profiles as potential targets for evaluating efficacy of Kai-Xin-San against APP/PS1 transgenic mice based on UPLC-Q/TOF-MS.
Zhang AH; Ma ZM; Kong L; Gao HL; Sun H; Wang XQ; Yu JB; Han Y; Yan GL; Wang XJ
Biomed Chromatogr; 2020 Feb; 34(2):e4724. PubMed ID: 31755117
[TBL] [Abstract][Full Text] [Related]
17. Multiple-matrices metabolomics combined with serum pharmacochemistry for discovering the potential targets and active constituents of Qifu decoction against heart failure.
Zhang X; Liao W; Ding X; Zhang Y; Long C; Zhou Q; Wang Y; Wu H; Tan G
J Pharm Biomed Anal; 2024 Jul; 244():116114. PubMed ID: 38522367
[TBL] [Abstract][Full Text] [Related]
18. Danggui Buxue decoction ameliorates lipid metabolic defects involved in the initiation of diabetic atherosclerosis; identification of active compounds.
Xue M; Bian Y; Liu Y; Zhou J; Xu J; Zhang L; Huang X
J Tradit Chin Med; 2020 Jun; 40(3):414-421. PubMed ID: 32506855
[TBL] [Abstract][Full Text] [Related]
19. Exploring lipid biomarkers of coronary heart disease for elucidating the biological effects of gelanxinning capsule by lipidomics method based on LC-MS.
Gao X; Hu XH; Zhang Q; Wang XJ; Wen XH; Wang Y; Zhang YX; Sun WJ
Biomed Chromatogr; 2021 Jul; 35(7):e5091. PubMed ID: 33618435
[TBL] [Abstract][Full Text] [Related]
20. Chinmedomics strategy for elucidating the effects and effective constituents of Danggui Buxue Decoction in treating blood deficiency syndrome.
Zhang Y; Yang Y; Ren J; Yan G; Yang L; Wu X; Kong L; Sun H; Han Y; Zhang X; Wang X
Front Mol Biosci; 2024; 11():1376345. PubMed ID: 38560521
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
